My watch list  

4 Current news from israel

matching the following criteria

Epigenomics Signs Distribution Deal with Pronto Diagnostics for Epi proColon in Israel

Epigenomics expands commercial reach for CE-marked product beyond home market


Epigenomics AG and Pronto Diagnostics Ltd. announced that they have signed an exclusive distributor agreement for the commercialization of Epigenomics’ Epi proColon test in Israel. Epi proColon is the world’s first CE-marked molecular diagnostic test for the early detection of colorectal cancer ...


Genetic clue to chronic pain could lead to new treatments for the condition


Chronic pain is a serious medical problem, afflicting approximately 20% of adults. Some individuals are more susceptible than others, and the basis for this remains largely unknown. In a report published in Genome Research, researchers have identified a gene associated with susceptibility to ...


Pluristem Therapeutics Announces Interim Top-Line Results From PLX-PAD Clinical Trials


Pluristem Therapeutics Inc. announced interim top-line results from its Phase I clinical trials utilizing its placenta-derived cell therapy product, PLX-PAD, for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD). The interim data demonstrated that ...


BioLineRx Initiates Phase I/II Trial of BL-5010 for the Non Surgical Removal of Skin Lesions


BioLineRx, a drug development company with products in advanced clinical and pre-clinical testing, announced the initiation of a Phase I/II clinical trial aimed at assessing the safety and efficacy of BL-5010, a novel formulation for the non surgical removal of skin lesions. The open-label, ...


Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE